Stockreport

Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients  

Bellerophon Therapeutics, Inc.  (BLPH) 
Last bellerophon therapeutics, inc. earnings: 4/6 10:23 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bellerophon.com
PDF Actigraphy is Being Utilized to Evaluate Multiple Clinically Meaningful Activity Parameters in the Ongoing INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary H [Read more]